We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $195M
1-Year Est. Return 12.04%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$283M
AUM Growth
-$9.71M
Cap. Flow
-$10.4M
Cap. Flow %
-3.69%
Top 10 Hldgs %
47.87%
Holding
80
New
8
Increased
28
Reduced
33
Closed
10

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$5.72M
2
LRCX icon
Lam Research
LRCX
+$4.94M
3
TREX icon
Trex
TREX
+$2.86M
4
SPLK
Splunk Inc
SPLK
+$1.24M
5
UNH icon
UnitedHealth
UNH
+$1.17M

Top Sells

Rank Stock Value
1
VMEO
Vimeo
VMEO
+$4.42M
2
BABA icon
Alibaba
BABA
+$4.34M
3
JYNT icon
The Joint Corp
JYNT
+$3.7M
4
RNLX
Renalytix plc American Depositary Shares
RNLX
+$2.71M
5
EAR
Eargo, Inc. Common Stock
EAR
+$1.51M

Sector Composition

Rank Sector Weight
1 Technology 28.92%
2 Consumer Discretionary 21.41%
3 Communication Services 13.33%
4 Healthcare 10.24%
5 Financials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
51
Boeing
BA
$171B
$375K 0.13%
1,706
-547
-24% -$122K
CHCT
52
Community Healthcare Trust
CHCT
$523M
$361K 0.13%
7,985
-250
-3% -$12.1K
NVDA icon
53
NVIDIA
NVDA
$4.86T
$357K 0.13%
+17,220
New +$358K
INDI icon
54
indie Semiconductor
INDI
$682M
$312K 0.11%
+25,350
New +$247K
PEP icon
55
PepsiCo
PEP
$190B
$297K 0.11%
1,975
-900
-31% -$139K
DBC icon
56
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$294K 0.1%
14,550
-1,150
-7% -$22.1K
NTLA icon
57
Intellia Therapeutics
NTLA
$1.49B
$293K 0.1%
2,185
-760
-26% -$115K
BEAM icon
58
Beam Therapeutics
BEAM
$2.63B
$250K 0.09%
2,875
-70
-2% -$7.03K
JYNT icon
59
The Joint Corp
JYNT
$118M
$242K 0.09%
2,470
-39,555
-94% -$3.7M
AWK icon
60
American Water Works
AWK
$26.7B
$222K 0.08%
1,315
+5
+0.4% +$874
CRSP icon
61
CRISPR Therapeutics
CRSP
$4.73B
$222K 0.08%
1,980
-805
-29% -$101K
SEER icon
62
Seer Inc
SEER
$122M
$212K 0.08%
+6,130
New +$211K
CMLTU
63
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
$191K 0.07%
18,600
-3,550
-16% -$37.1K
CRDF icon
64
Cardiff Oncology
CRDF
$66.5M
$111K 0.04%
+16,625
New +$104K
LUNA
65
DELISTED
Luna Innovations Incorporated
LUNA
$95K 0.03%
+10,000
New +$108K
ZNGA
66
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$90K 0.03%
12,000
– –
PPTA
67
Perpetua Resources
PPTA
$2.3B
$54K 0.02%
10,791
-1,892
-15% -$10.6K
BABA icon
68
Alibaba
BABA
$293B
– –
-19,136
Closed -$4.34M
CCI icon
69
Crown Castle
CCI
$33.3B
– –
-2,845
Closed -$555K
EDIT icon
70
Editas Medicine
EDIT
$396M
– –
-4,105
Closed -$233K
PACB icon
71
Pacific Biosciences
PACB
$435M
– –
-6,165
Closed -$216K
VMEO
72
DELISTED
Vimeo
VMEO
– –
-90,179
Closed -$4.42M
XOM icon
73
ExxonMobil
XOM
$644B
– –
-3,600
Closed -$227K
RNLX
74
DELISTED
Renalytix plc American Depositary Shares
RNLX
– –
-87,975
Closed -$2.71M
CPARU
75
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
– –
-22,150
Closed -$224K
1 2
3
4

Similar funds

HAS
Horizon Advisory Services West Henrietta, New York $195M AUM 14.6% 1-Year Est. Return
MHFA
Mission Hills Financial Advisory San Diego, California $195M AUM 8.43% 1-Year Est. Return
TF
Tudor Financial Dayton, Ohio $196M AUM 19.08% 1-Year Est. Return
RAM
Revere Asset Management Dallas, Texas $195M AUM 80.44% 1-Year Est. Return
ICMARC
International City Management Association Retirement Corp Washington, District of Columbia $195M AUM 10.82% 1-Year Est. Return
CPRPA
Cerity Partners Retirement Plan Advisors New York $196M AUM
CPI
Crestview Partners III New York $195M AUM 17.49% 1-Year Est. Return
MAMF
Mirabaud Asset Management (France) Paris, France $196M AUM

Scholtz & Company's Q3 2021 Portfolio in Review

As of Q3 2021, Scholtz & Company held 80 positions worth $283M, down 3.3% from $292M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Scholtz & Company withdrew a net $10.4M in Q3 2021, closing 10 positions and reducing 33 holdings. Its most notable exit was Vimeo, an estimated $4.42M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Scholtz & Company opened a new position in Marvell Technology worth $5.75M.

  • Scholtz & Company's largest Q3 2021 buy was Marvell Technology: 95,397 shares worth $5.75M.
  • Scholtz & Company added most to Trex in Q3 2021, an estimated $2.86M increase.
  • Scholtz & Company's biggest Q3 2021 reduction was The Joint Corp, cutting an estimated $3.7M.
  • Scholtz & Company fully exited Vimeo in Q3 2021, selling an estimated $4.42M.
  • Scholtz & Company's ten largest holdings make up 48% of its $283M portfolio in Q3 2021.
  • Scholtz & Company opened 8 new positions and closed 10 in Q3 2021.
  • Scholtz & Company's portfolio value fell 3.3% quarter-over-quarter to $283M.

Based on Scholtz & Company's 13F filing for Q3 2021, filed 15 Nov 2021.